The Efficacy and Safety of Sibutramine for Weight Loss
- 10 May 2004
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 164 (9) , 994-1003
- https://doi.org/10.1001/archinte.164.9.994
Abstract
Research from JAMA Internal Medicine — The Efficacy and Safety of Sibutramine for Weight Loss — A Systematic ReviewThis publication has 34 references indexed in Scilit:
- Prevalence and Trends in Obesity Among US Adults, 1999-2000JAMA, 2002
- The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessmentHealth Technology Assessment, 2002
- Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-AnalysesAnnals of Internal Medicine, 2001
- Anti-obesity drugs: a critical review of current therapies and future opportunities.Pharmacology & Therapeutics, 2001
- The Disease Burden Associated With Overweight and ObesityJAMA, 1999
- Pharmacological treatment of obesity: present statusInternational Journal of Obesity, 1999
- Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: Executive SummaryThe American Journal of Clinical Nutrition, 1998
- Meta-analysis: Principles and proceduresBMJ, 1997
- Bias in meta-analysis detected by a simple, graphical testBMJ, 1997
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996